Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis.
about
Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lungEGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistanceResearch progress of thyroid transcription factor-1 as molecular marker in lung carcinomaPulmonary adenocarcinoma: a renewed entity in 2011Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II study.ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung.Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significanceLysyl hydroxylase 2 induces a collagen cross-link switch in tumor stromaIntersections between pulmonary development and disease.Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinomaAn Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.Thyroid transcription factor-1 expression is significantly associated with mutations in exon 21 of the epidermal growth factor receptor gene in Chinese patients with lung adenocarcinoma.Genetic and biochemical alterations in non-small cell lung cancer.Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1)Comparison of immunohistochemistry and mRNA in situ hybridization in detecting thyroid transcription factor-1 expression in non-small cell lung carcinomas tissue.Distinct Characteristics of Small Cell Lung Cancer Correlate With Central or Peripheral Origin: Subtyping Based on Location and Expression of Transcription Factor TTF-1Cancer genes in lung cancer: racial disparities: are there any?CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinomaThe complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activitiesETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer.EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate.EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.Lineage factors and differentiation states in lung cancer progression.LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.Evaluation of the microvessel density and the expression of metalloproteases 2 and 9 and ttf1 in the different subtypes of lung adenocarcinoma in Tunisia: a retrospective study of 46 cases.Distinct prognostic roles and heterogeneity of TTF1 copy number and TTF1 protein expression in non-small cell lung cancer.Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.Prognostic relevance of TTF-1 expression in stage I adenocarcinoma.Strategies for identification of somatic variants using the Ion Torrent deep targeted sequencing platform.Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer.A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients.Opposite roles of FOXA1 and NKX2-1 in lung cancer progression.EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases.
P2860
Q24303485-0EA14AB0-AFBD-425D-B6A3-72140405D92BQ24335999-C0A03258-B18F-456D-9850-0D2C56F976C4Q26826821-20AF4682-527B-4118-9F4A-5FEB8CCDBF2AQ28395348-4F14F80D-8176-4543-ABF0-482C4CBC16A3Q34245704-FAD27AEF-AA22-4F0E-91AD-924A441376ABQ34383742-35CE83FB-DD69-4AFA-8904-C4B817DC2731Q34781380-EA74DD14-559C-460A-925E-B708B5CE5505Q34785969-0C3045C5-93BD-485B-ABB0-BDDD64DD4961Q35183870-D5F90189-DCE5-4B00-A909-1038BC6A99FFQ35219746-44B55680-AAE8-447F-A434-202A3B416BD4Q35632022-712DE3DE-1102-4363-ABF0-FA048A1FA92DQ35653082-08EF3BA9-D033-4037-BFFB-479631F98D36Q35920986-D79A6BB7-7A25-4171-A7F1-4A139B50FED5Q36013991-C2980E1A-44B9-43F3-985D-2C0701C4EE14Q36065174-A6F9D91E-31E4-4667-B0F9-9BB3F5D67132Q36184584-8397C039-1BC4-4A0B-8928-E572968BA30BQ36217272-D3C7F75B-BE5D-4AC3-9EC1-2F47EA1E5967Q36334237-5518C487-2472-4810-BFA3-BFEFE33D8106Q36421052-7885A44D-FD1C-415A-A7F0-BABC27EE1683Q36481954-38AEBE9E-4073-404A-932C-372DE4FA3412Q36544886-A023270B-8A54-413B-BB81-86642EDFF61BQ36952749-1C52DDDD-29FB-470F-92B0-D5A6CAB16550Q37132018-72A208C3-3053-4468-BCAA-AD23B86E28F2Q37355527-B1507016-AB87-46FE-BB61-91C2240764AEQ37472017-E25CFE4F-0059-4129-9F36-2AB77C64D64BQ37514797-231D3FEB-E276-4521-B09D-7AA7AC879A76Q38379393-E0069442-7FE5-4B47-8FBB-D663D7E47FD1Q38395972-666606C6-EE79-4285-861C-C0DE03E3D560Q39101598-31D7CD30-C14D-423A-92DC-941010763D55Q39256505-D59E0B5F-281B-469C-A5F4-5C9196758304Q40257398-7CC6835C-7136-4952-8BC5-94B482C2E32AQ40559745-1F48DA1D-1FD9-4DB4-894A-98451BC249D4Q41401802-DCC732CC-933D-4809-AB04-7131E96CC53BQ47110752-F86334E4-FF88-4D7E-8778-766EF687B579Q47122149-626584F3-A49D-4B2D-81B6-9BAC18D451EEQ47131652-FC77FC62-CD7F-47E3-9860-B486273C1293Q47140337-AAC9C311-FDC0-4FD4-AD75-BA030BB52DBDQ48632489-94C51FEE-75A1-42EB-85D1-95F5A87F63B4Q54441930-FC29FC8F-169E-4332-AD26-5ABFAADA4E64
P2860
Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Abnormalities of the TITF-1 li ...... er pathogenesis and prognosis.
@ast
Abnormalities of the TITF-1 li ...... er pathogenesis and prognosis.
@en
Abnormalities of the TITF-1 li ...... er pathogenesis and prognosis.
@nl
type
label
Abnormalities of the TITF-1 li ...... er pathogenesis and prognosis.
@ast
Abnormalities of the TITF-1 li ...... er pathogenesis and prognosis.
@en
Abnormalities of the TITF-1 li ...... er pathogenesis and prognosis.
@nl
prefLabel
Abnormalities of the TITF-1 li ...... er pathogenesis and prognosis.
@ast
Abnormalities of the TITF-1 li ...... er pathogenesis and prognosis.
@en
Abnormalities of the TITF-1 li ...... er pathogenesis and prognosis.
@nl
P2093
P2860
P1476
Abnormalities of the TITF-1 li ...... er pathogenesis and prognosis.
@en
P2093
Adi F Gazdar
Carmen Behrens
Cesar Moran
David Rice
Diane D Liu
Humam Kadara
J Jack Lee
Junya Fujimoto
Marileila Varella-Garcia
Waun Ki Hong
P2860
P304
P356
10.1158/1078-0432.CCR-10-1412
P407
P577
2011-01-21T00:00:00Z